Epithelial Malignant Tumors of the Cervix: Neuroendocrine Tumors Book Section


Authors: Forgó, E.; Howitt, B. E.
Article/Chapter Title: Epithelial Malignant Tumors of the Cervix: Neuroendocrine Tumors
Abstract: Neuroendocrine tumors of the cervix are epithelial neoplasms with morphologic and immunophenotypic evidence of neuroendocrine differentiation. This group of tumors includes low-grade neuroendocrine tumors (grades 1–2) and high-grade neuroendocrine carcinomas (grade 3), the latter of which may be either small cell or large cell type. Overall, neuroendocrine tumors are rare comprising 2% of all invasive cervical neoplasms, the majority of which are small cell carcinomas. In most cases, high-risk human papillomavirus (HPV) type 16 or 18 is identified as an etiologic factor. Treatment for early-stage, high-grade neuroendocrine carcinomas is radical hysterectomy, followed by adjuvant chemotherapy or chemoradiation. The prognosis of low-grade neuroendocrine tumors of the cervix is related to the disease stage. Grade 1 neuroendocrine tumors of the cervix portend the best prognosis. High-grade neuroendocrine carcinomas are associated with poor clinical outcome for all stages, with high recurrence rates and a 5-year survival of 15% to 40%. © Springer Nature Switzerland AG 2021.
Keywords: chemotherapy; medical imaging; tumors; diagnosis; cell types; medical computing; malignant tumors; low grade; biomedical engineering; neuroendocrine tumors; cell carcinoma; human papilloma virus; high grades; morpho-logics; small cells; tumour grade
Book Title: Atlas of Diagnostic Pathology of the Cervix: a Case-Based Approach
ISBN: 978-303049954-9
Publisher: Springer  
Date Published: 2020-01-01
Start Page: 229
End Page: 238
Language: English
DOI: 10.1007/978-3-030-49954-9_10
PROVIDER: scopus
DOI/URL:
Notes: Book chapter -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics